Inhaled vasodilators in acute lung injury

D.M. Payen

Source: Eur Respir Mon; 2002: 20: 129–142
Journal Issue: ARDS
Disease area: Pulmonary vascular diseases

PDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D.M. Payen. Inhaled vasodilators in acute lung injury. Eur Respir Mon; 2002: 20: 129–142

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Endogenous endothelins and nitric oxide in hypoxic pulmonary vasoconstriction
Source: Eur Respir J 2003; 21: 19-24
Year: 2003



Acute vasoresponsiveness to inhaled nitric oxide in sarcoidosis-associated pulmonary hypertension
Source: Annual Congress 2008 - Clinical aspects in the management of sarcoidosis
Year: 2008


Cardiopulmonary effects of iloprost in experimental acute lung injury
Source: Eur Respir J 2005; 25: 81-87
Year: 2005



Haemodynamic testing in primary pulmonary hypertension - effects of nitric oxide, iloprost and oxygen
Source: Eur Respir J 2001; 18: Suppl. 33, 414s
Year: 2001

The effect of inhaled nitric oxide on the cardiac performance in patients with hypoxic pulmonary hypertension
Source: Eur Respir J 2003; 22: Suppl. 45, 269s
Year: 2003

Comparative effects of inhaled nitric oxide and aerosolized iloprost during vasoreactivity testing in chronic pulmonary hypertension
Source: Eur Respir J 2005; 26: Suppl. 49, 561s
Year: 2005

The vasodilator response to inhaled nitric oxide (iNO) predicts the short term evolution with oral vasodilators in pulmonary arterial hypertension
Source: Eur Respir J 2001; 18: Suppl. 33, 3s
Year: 2001

Sepsis and hyperoxia effects on the pulmonary surfactant system in wild-type and iNOS knockout mice
Source: Eur Respir J 2002; 20: 177-182
Year: 2002



Correlation of inhaled nitric-oxide induced reduction of pulmonary artery pressure and vascular changes
Source: Eur Respir J 2002; 20: 52-58
Year: 2002



Replacement of physiologically autoinhaled nitric oxide in intubated patients
Source: Eur Respir J 2003; 21: 677-681
Year: 2003



Cirrhosis ameliorates monocrotaline-induced pulmonary hypertension in rats
Source: Eur Respir J 2009; 34: 731
Year: 2009



Response to hypoxia of pulmonary arteries in chronic obstructive pulmonary disease: an in vitro study
Source: Eur Respir J 2002; 20: 332-338
Year: 2002



Arterial stiffening in asthma exacerbation is connected with systemic inflammation, oxidative disbalance, hypoxemia and nitric oxide plasma level
Source: Eur Respir J 2007; 30: Suppl. 51, 552s
Year: 2007

Lung allergic inflammation and stress: effects of capsaicin neonatal treatment on pulmonary mechanics and exhaled nitric oxide in stressed rats
Source: Eur Respir J 2002; 20: Suppl. 38, 105s
Year: 2002

Inhaled nitric oxide (NO) for vasoreactivity testing in pulmonary hypertension
Source: Eur Respir J 2003; 22: Suppl. 45, 584s
Year: 2003

Aerosolized PGE1, PGI2 and nitroprusside protect against vascular leakage in lung ischaemia-reperfusion
Source: Eur Respir J 2001; 18: 15-22
Year: 2001



Bronchial nitric oxide is related to symptom relief during fluticasone treatment in COPD
Source: Eur Respir J 2010; 35: 72-78
Year: 2010



Combination of inhaled nitric oxide and an endothelinA-receptor antagonist in acute pulmonary thromboembolism
Source: Eur Respir J 2003; 22: Suppl. 45, 463s
Year: 2003

Influence of inhaled nitric oxide on plasma endothelin-1 in pulmonary hypertension
Source: Eur Respir J 2003; 22: Suppl. 45, 463s
Year: 2003

The acute haemodynamic effects of 'pulsed' inhaled nitric oxide and iv epoprostenol in patients with pulmonary hypertension
Source: Eur Respir J 2003; 22: Suppl. 45, 584s
Year: 2003